Manny Ted B, Gorbachinsky Ilya, Hemal Ashok K
Department of Urology, Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157, USA.
Can J Urol. 2010 Oct;17(5):5390-3.
To describe the incidence and outcomes of lower extremity neuropathies in a series of robot assisted laparoscopic radical prostatectomy (RALRP) and robot assisted laparoscopic radical cystectomy (RALRC) patients with 9 months follow up. Additionally, we compare this cohort to other published series of lithotomy based surgery and describe strategies for minimizing risk.
We performed a retrospective analysis of 179 consecutive patients who underwent either RALRP or RALRC at a single institution during a 17 month period. We included all patients who experienced bothersome lower extremity pain, weakness, or numbness at any time during their postoperative course. We further defined postoperative neuropathy as de-novo symptoms presenting in the first week postoperatively. Chart review and telephone survey were used to further characterize these patients.
Six out of 179 patients complained of lower extremity neuropathic symptoms by 9 months of follow up. Probable injuries to the common peroneal, lateral femoral cutaneous, and obturator nerves were found. Three patients met our criteria for postop neuropathy making the incidence 1.68%. All patients remained ambulatory throughout their course. At 9 months follow up, only one patient, a man with metastatic bladder cancer, had activity limiting neuropathic symptoms.
With routine use of common risk minimizing strategies, RALRP or RALRC may result in lower extremity europathy at rates similar to other lithotomy based procedures described in the literature.
描述一系列接受机器人辅助腹腔镜根治性前列腺切除术(RALRP)和机器人辅助腹腔镜根治性膀胱切除术(RALRC)且随访9个月的患者下肢神经病变的发生率及预后。此外,我们将该队列与其他已发表的基于截石位手术的系列研究进行比较,并描述降低风险的策略。
我们对在17个月期间于单一机构接受RALRP或RALRC的179例连续患者进行了回顾性分析。纳入所有在术后过程中任何时间出现下肢疼痛、无力或麻木等困扰症状的患者。我们将术后神经病变进一步定义为术后第一周出现的新发症状。通过查阅病历和电话调查来进一步描述这些患者的情况。
在179例患者中,6例在随访9个月时抱怨有下肢神经病变症状。发现可能存在腓总神经、股外侧皮神经和闭孔神经损伤。3例患者符合我们的术后神经病变标准,发生率为1.68%。所有患者在整个病程中均能行走。在9个月的随访中,只有1例患有转移性膀胱癌的男性患者有影响活动的神经病变症状。
通过常规采用常见的降低风险策略,RALRP或RALRC导致下肢神经病变的发生率可能与文献中描述的其他基于截石位的手术相似。